Viewing on a PDA? Click here to read this email.
Medical Progress Today
mpt home | sign up

Volume 7, Number 30
July 29, 2010


PRINTER FRIENDLY

In the Spotlight

"OPM Alternative" is the Public Option

Stuart Butler, National Journal, 7-26-10

The Democrats' new public option proposal underscores the point I made recently that the "health reform wars have only just begun." Issues like the public option; who will ultimately run the exchanges; and how we will actually control health spending all remain in play and will have to be resolved.
Continue reading . . .

News

· Medical Device Recalls and the FDA Approval Process, Zuckerman, D. M., Brown, P., Nissen, S. E., Archives of Internal Medicine, 6-14-11
· Patent Reform Gets Key Support in House, Julian Pecquet, The Hill, 6-14-11
· $4.3 Billion Pledged at Vaccine Fund-Raiser, Donald G. McNeil Jr., New York Times, 6-13-2011
· Physicians Leaving Practices for health System Employment, Karen Cheung, FierceHealthcare, 6-13-11

More Headlines >>


Commentary

· Marco Rubio takes on 'Medi-scare' Marc A. Thiessen, Washington Post, 6-13-11
· 'Vouchercare' Is the Right Name for Medicare Laurence Kotlikoff, Bloomberg, 6-15-11
· Built To Fail: Health Insurance Exchanges Under The Affordable Care Act
· Can Exchanges Help Consumers Get Good Value Insurance? Depends On Where You Live Sabrina Corlette, Kaiser Health News, 6-15-11
· The ObamaCare Bad News Continues Karl Rove, Wall Street Journal, 6-16-11
· ObamaCare's Economic Flaws Doug Holtz-Eakin, Investor's Business Daily, 6-8-11

More Commentary >>


Research

· Why States Are So Miffed about Medicaid Economics, Politics, and the "Woodwork Effect", Benjamin D. Sommers et al., New England Journal of Medicine, 6-15-11
· Auditing Access to Specialty Care for Children with Public Insurance, Joanna bisgaier et al., New England Journal of Medicine, 6-16-11
· Moving Beyond Fee-For-Service: The Case for Managed Care in Medicaid, Michael Ramlet and Carey Lafferty, American Action Forum, 6-14-11
· The New Gold Rush: Prospectors are Hoping to Mine Opportunities in the Healthcare Industry, Health Research Institute, PricewatershouseCoopers, 6-14-11
· Active Purchasing for Health Insurance Exchanges: An Analysis of Options, Sabrina Corlette and JoAnn Volk, RWJF, 6-14-11

More Research>>



Medical Progress Today is published by the Center for Medical Progress at the Manhattan Institute for Policy Research.

For more information about Medical Progress Today, please contact the managing editor, Paul Howard, at phoward@manhattan-institute.org, or via telephone at 212.599.7000.

Press inquiries regarding Medical Progress Today can be directed to the Communications Department, at communications@manhattan-institute.org, or via telephone at 212.599.7000.

If you would like to unsubscribe, please reply to us and type "Unsubscribe" in the subject line.

MPT on Facebook Find us on Twitter

SPOTLIGHT

"OPM Alternative" is the Public Option

INNOVATIVE IDEAS:
Podcast Series


COLLABORATE TO INNOVATE: HOW THE FDA IS ADVANCING PERSONALIZED MEDICINE THROUGH NEW PARTNERSHIPS
Dr. Janet Woodcock, director of the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration, and Paul Howard discuss genetic testing, the role of the FDA in regulation, and the importance of public-private collaboration.

Click here to listen to the podcast.

"No company wants to develop new clinical trial methods; that's not their business. . . . However we need new scientific trial methods, for example to evaluate use of genetic tests along with new drugs that come along, and so we need to come together in different ways to develop that regulatory science."
—Janet Woodcock

 

Center for Medical Progress 
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000
mpt@manhattan-institute.org